Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Advisory Committees

Briefing Information for the June 2, 2009 Meeting of the Anti-Infective Drugs Advisory Committee

FDA

Disclaimer

 

Portions of this document have been determined to be exempt from disclosure under the Freedom of Information Act (the FOIA) (5 U.S.C. § 552).

FDA Briefing Material (pdf)

Appendix A (pdf)

Appendix B (pdf)

Errata (pdf)

 

Advanced Life Sciences

  Disclaimer

 

The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.

Briefing Material (pdf)

Page Last Updated: 12/09/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.